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prevalence are 8.7 - 12.0% for the 2005 survey and 7.2 - 10.4% 
for the 2008 survey. In other words, the confidence intervals of 
estimates from the various surveys overlap to such an extent 
for it to be quite probable that the differences between these 
estimates are nothing more than random fluctuation.
Of course, none of this is to say that there has not been 
a fall in incidence at the younger ages. It says only that if 
there has been such a fall, the survey is much too small to 
detect it. And while the survey presents evidence of reported 
changes in behaviour that might support the possibility of 
falling incidence in youth, it is difficult to know how accurate 
responses to these questions are. Certainly, if there have been 
changes in behaviour they are not substantial enough to impact 
on the proportion of pregnancies to teenage mothers, as the 
proportion of teenagers attending public antenatal clinics has 
remained fairly constant at around 19 - 20% for a number of 
years and certainly from 2002 to 2007.10,11 The changes are 
therefore unlikely to have been substantial enough to impact 
significantly on the incidence in teenagers.
It will be interesting to see if the dramatically lower 
incidence among teenagers estimated in the report is supported 
in any way by the results of the 2008 national antenatal 
survey, hopefully to be released later this year. (Although it 
might appear from the antenatal survey results that there has 
been a decline in prevalence among teenagers since 2005, it 
is impossible to tell to what extent this is simply due to the 
significant change in sample from 2006. There is no evidence of 
a decline in prevalence in this age group from 2002 to 2005 or 
after 2006.)
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National population-based surveys that include HIV testing 
are considered to be the ‘gold standard’ to measure HIV 
prevalence at a country level, since such surveys include men, 
non-pregnant women and children, and hence a much wider 
proportion of the population than do antenatal surveys.1 Three 
national HIV household surveys have been conducted in South 
Africa, the first in 2002, then in 2005 and 2008. These collected 
data on HIV status, socio-demographic factors and behavioural 
determinants as well as exposure to prevention programmes 
which greatly enhanced the analysis and interpretation of the 
trends in HIV infection.2  
In his appraisal of the 2008 survey report in this issue of 
SAMJ, Dorrington3 questions the reliability of the survey 
findings and expresses concerns about the validity of our 
conclusions. He compares the HIV prevalence data obtained 
in the surveys with the estimates produced by his model, 
the ASSA AIDS and Demographic Model.4 Findings that 
were not close enough to those projected by the ASSA model 
are declared ‘not in line with expectation’ and therefore 
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empirical data that greatly improved the outputs of projection 
models. A prime example of this process is the ASSA model: 
the ASSA estimates of HIV-infected people for the year 2005 
dropped from 7.6 million to 5.2 million (!) after the creator of 
the model re-calibrated the projections with data available from 
the national HIV household surveys.5,6
The 2008 survey report focused on the indicators selected for 
measuring progress in the implementation of the South African 
National Strategic Plan. In the plan for 2007 - 2011, the Human 
Sciences Research Council (HSRC) is requested to adjust the 
scope of analysis in order to accommodate this requirement. It 
is therefore surprising that Dorrington argues that it will be of 
little comfort to policy-makers. 
The ASSA2003 model estimates of HIV prevalence by 
age correlate well with the results of the 2008 HSRC survey. 
However, Dorrington’s interpretation that the increase in HIV 
prevalence from 2005 to 2008 in females 30 years and older 
is implausible needs to be addressed. Firstly, the prevalence 
among females 30 years and older was 13.6% in 2005 and 
15.7% in 2008, an increase of 2.1%, which is more likely to be 
a result of increased access to antiretroviral treatment (ART) 
among women over 30 years than of an increase in HIV 
incidence. ART has increased the survival time of people living 
with HIV, and as a consequence HIV prevalence is likely to 
increase predominantly in the age groups more likely to need 
ART. This should be borne in mind when interpreting the 2008 
findings on HIV prevalence.  
Dorrington’s assessment of the survey data suffers from 
serious inaccuracies. For example, in his comparison of HIV 
prevalence differences calculated from the 2002 and 2008 
national household surveys and the 2002 and 2007 antenatal 
surveys respectively, he uses HSRC prevalence data from the 
age group 2 years and older instead of the appropriate 15 - 49 
years age group. Table I shows the pattern of HIV prevalence 
trends in this age group by province for the corresponding 
survey periods (household surveys 2002 - 2008 v. antenatal 
surveys 2002 - 2007).  The provincial prevalence trends 
observed in the national household surveys and the antenatal 
surveillance surveys were overall in good agreement, with 
6 of the 9 provinces showing the same trends in both survey 
methodologies. On the national level, the difference in HIV 
prevalence between the 2002 and 2008 national household 
surveys  was +1.3%, and the difference between the 2002 and 
2007 antenatal surveys was +1.5%.7,8
Trends over time are powerful tools to assess whether the 
observed changes are real, especially when the uncertainty 
around single survey estimates is brought into epidemiological 
context. Among children aged 2 - 14 years, a decline in HIV 
prevalence has been observed from 2002 to 2005 and from 2005 
to 2008, and the difference between 2002 and 2008 reached 
statistical significance. But more important, the decline is 
also epidemiologically plausible. The increasing coverage of 
effective prevention of mother-to- child-transmission (PMTCT) 
programmes in the country has certainly shown its impact 
on the vertical transmission of HIV, with fewer HIV-infected 
infants moving each year into the 2 - 14-year age cohort. On the 
basis of this contextual evidence we argue that the observed 
decline in HIV prevalence was real. However, the increasing 
number of HIV-infected children receiving antiretroviral 
treatment will make interpretation of their HIV prevalence 
levels increasingly difficult in future. 
HIV prevalence trends in teenagers aged 15 - 19 years and 
youth aged 20 - 24 years are shown in Table II. A decline in 
HIV prevalence was observed for both age groups from 2005 to 
2008. In view of the reported substantive behavioural changes 
among youth between the 2005 and 2008 surveys we consider 
these declines in HIV prevalence plausible and more than just 
the result of statistical fluctuation. This is illustrated in Fig. 1, 
which shows reported condom use at last sex in the 15 - 24 age 
group in the three surveys. The increases in condom use at last 
sex were statistically significant in both male and female youth. 
Dorrington dismissed the decline in HIV infection rates 
among teenagers aged 15 - 19 years who participated in the 
Table II. HIV prevalence among youth, South Africa 2002, 2005 and 2008
       2002         2005         2008
Age group (yrs) N HIV %      95% CI N HIV %      95% CI N HIV %        95% CI
Youth (15 - 19) 1 143 5.9      4.0 - 8.8 2 154 5.9       4.3 - 8.0 1 928 4.4        3.0 - 6.5
Youth (20 - 24) 956 13.2      10.4 - 16.7 1 966 15.2      12.5 - 18.2 1 689 13.6        11.4 - 16.2
Table I. HIV prevalence trends by province, 15 - 49-year 
age group: national household surveys v. antenatal surveys
  Household survey          Antenatal survey
Province     (2002 - 2008)            (2002 - 2007)
KwaZulu-Natal             ↑       ↑
Mpumalanga             ↑       ↑
Free State             ↓       ↑
Gauteng             ↓       ↓
Northwest             ↑       ↑
Eastern Cape             ↑       ↑
Limpopo             ↑       ↑
Northern Cape             ↑       ↑
Western Cape             ↓       ↑
National             ↑       ↑
↑ represents an increase and ↓ a decrease in trend.
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2008 national HIV household survey as an unlikely result 
because similar declines were not observed in pregnant female 
teenagers attending public health clinics. This is like comparing 
apples with oranges. Clearly it stands to reason that pregnant 
teenagers are not representative of 15 - 19-year-old old boys 
and girls in the general population. Teenage pregnancies are 
associated with a socio-demographic and behavioural risk 
profile that greatly increases the risk of HIV infection. This 
is shown in Table III, which compares HIV prevalence levels 
among the different teenage groups. The HIV infection rate 
in pregnant teenagers was 11.2%, over 2.5 times higher than 
the prevalence found in the whole group, 4.4% for males and 
females combined. However, it was close to the prevalence 
estimate for teenagers attending public antenatal clinics in 
2007. Given the inherent risk profile associated with teenage 
pregnancy, we expect that the results will be similar in the 2008 
antenatal survey.
Extrapolations from antenatal data to the general population 
should be made with caution. Antenatal sentinel data are 
subject to biases related to sampling, usage and coverage of 
selected antenatal services, differentials in risk behaviours 
and contraceptive use, and other socio-demographic factors 
(e.g. age distribution of pregnant women visiting antenatal 
clinics).1 Taking into account the differential utilisation rate 
of public health services by race group in South Africa, Table 
IV compares HIV prevalence in all females as well as black 
females with pregnant females attending antenatal clinics in 
2007. It is apparent that the HIV prevalence profile among 
black females participating in the 2008 national household 
survey is very similar to the 2007 antenatal survey, except 
among the young females.
HIV prevalence is the result of cumulative new infections 
(incidence) and cumulative deaths among HIV-infected persons 
over time. This epidemiological paradigm provides the basis 
for methods that estimate HIV incidence from HIV prevalence 
data.9,10 Applying a mathematical approach, we have derived 
HIV incidence estimates from prevalence in young people 
aged 15 - 20 years (males and females combined) using 
prevalence data by single year of age and assuming that HIV 
prevalence differences between the age strata represent incident 
HIV infections. The change in the HIV incidence pattern 
was substantial for the 2008 survey year compared with the 
incidence figures calculated for the 2002 and 2005 survey years, 
especially for the single-year age groups 15, 16, 17, 18, and 
19 years.2  This straightforward method is best applicable in 
younger age groups when the effect of AIDS-related mortality 
on HIV prevalence levels is still minimal. We are currently 
extending the epidemiological HIV incidence estimation to 
the entire population 15 years and older, using a recently 
proposed method that infers population-level HIV incidence 
from prevalence obtained in two cross-sectional serosurveys.11 
The approach incorporates survival after infection and hence 
requires information of ART exposure in the study population. 
One of the novelties of the 2008 survey was the addition of 
ARV testing into the survey protocol, which will enable this 
type of analysis. 
With all modelling approaches we should keep in mind the 
famous quote from George Edward Pelham Box, one of the 
greatest statisticians of the 20th century and a pioneer in the 
area of Bayesian inference: ‘Essentially, all models are wrong, 
but some are useful.’12 Substantial improvements have been 
made over the past years in modelling country-level HIV/
AIDS epidemics. The UNAIDS Estimation and Projection 
Package (EPP), the tool of choice for preparing national 
estimates and projections in most of sub-Saharan Africa, has 
recently added uncertainty estimation in its projections for 
Table III. HIV prevalence (%) in 15 - 19-year age group: national household survey 2008 v. antenatal survey 2007 
Age group (yrs)  Both sexes            Females  Pregnant females*        Antenatal  survey 2007
15 - 19          4.4                 6.7             11.2       12.9




Age group         HSRC 2008           HSRC 2008             Antenatal
(yrs)           all females            black females        survey 2007
15 - 19  6.7             7.8            12.9
20 - 24  21.1             24.3           28.1
25 - 29  32.7             38.9           37.9
30 - 34  29.1             36.2           40.2
35 - 39  24.8             33.0           33.2
40 - 49  15.3             22.2           21.5
   Total  21.3             26.6           28.0


































































Fig. 1. Condom use at last sex, 15 - 24-year-olds.
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generalised epidemics.13 We recommend that future versions 
of the ASSA model should also incorporate this capability 
of uncertainty analysis in order to present model estimates 
with 95% confidence bounds. This would greatly improve the 
comparison of ASSA outputs with empirical data from national 
population-based surveys.
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Professor Dorrington responds:
Three major concerns about the analysis and reporting of 
the latest HSRC results were raised in my article, namely the 
potential for bias (given the low response rates), the lack of 
acknowledgement of uncertainty in the results, and the use 
of the results from the 2002 survey as the basis for implying 
trend. None of these issues has been dealt with in a satisfactory 
manner by Rehle and Shisana.
Their response does not address the question of bias. 
However, through providing survey results not published 
in the report, they inadvertently provide grounds for further 
concern on this issue with their comparisons in Tables III and 
IV, which purport to show the similarity between estimates 
from the survey and those from the 2007 antenatal survey (to 
which they assume the 2008 survey will be ‘similar’). Bearing 
in mind the need for upward adjustment of the 2007 antenatal 
survey figures,1,2 both comparisons show the prevalence from 
the HSRC survey to be somewhat lower (2.7% lower than the 
correct figure for 20071,2 in the case of the black women aged 15 
- 49 years) than the figures with which the authors argue they 
should be comparable. Of course, given that probably around 
90%3 of those tested in the national antenatal sample are black 
women, one must wonder why the authors chose not to use the 
prevalence among pregnant black women in their comparisons, 
as in past surveys (instead of pregnant women in Table III and 
all black women in Table IV). 
The potential for bias is a crucial question deserving more 
debate. Arguments presented elsewhere by the authors (e.g. 
South African National AIDS Council and a UCT research 
seminar) that suggest that the survey is unbiased, either on the 
basis of research by Mishra and colleagues4,5 into this question 
with respect to household prevalence surveys carried out as 
part of the DHS surveys or on the basis of comparisons of the 
characteristics of the people who answered the questionnaire 
but did or did not agree to be tested, are problematic.
To the criticism that it would be more useful and honest 
to acknowledge the uncertainty and publish the confidence 
intervals, the authors’ response is that they regard 
‘epidemiological plausibility’ as being ‘more important’ 
than statistical significance. They argue that the decrease in 
prevalence among children aged 2 - 14, from an implausible 
5.6% in 2002 to a more sensible 2.5% in 2008, is ‘real’ based on 
the ‘contextual evidence’ that coverage of effective PMTCT 
programmes has increased. They present no quantitative 
evidence to explain how a programme preventing infection in 
infants and with low coverage between 2002 and 2005 might 
explain, in an ‘epidemiologically plausible’ way, that the bulk 
of the drop (5.6% to 3.3%) in prevalence among children aged  
2 - 14 occurred between 2002 and 2005!
Similarly they argue that the drop in prevalence in the 
youth is plausible in the light of their ‘reported substantive 
behavioural changes’. Ignoring the question about whether 
reported behaviour is actual behaviour, it is curious that the 
reported drop in knowledge (also statistically significant) in the 
youth, the increase in percentage of males with more than one 
partner in the past year, and the fall in the age of sexual debut 
of males are not mentioned as indicators of changes in sexual 
behaviour. 
Furthermore, the argument that comparing the trend in 
prevalence in 15 - 19-year-olds as measured by the survey with 
the trend in the prevalence of 15 - 19-year-olds attending public 
antenatal clinics is ‘like comparing apples and oranges’ misses 
the point. If condoms are being used to prevent the spread of 
the disease and are the major source of contraception, then: 
(i) one would expect to see a change in the age distribution of 
women attending public antenatal clinics (which one doesn’t 
see); and, more importantly, (ii) if the prevalence in young 
women is falling to the extent suggested by the report, then 
surely one would have expected to see the prevalence among 
pregnant women (as measured by the antenatal survey) falling 
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too (which it doesn’t appear to be doing). Unless, of course, 
the suggestion is that prevalence is only falling in women who 
wouldn’t have fallen pregnant had they had unprotected sex! 
Finally, of the concern that 2002 is used as a basis for 
inferring trend the authors point out, quite correctly, that the 
change in prevalence from the HSRC survey shown in Table 
III of the article is that for the population aged 2 and older, 
whereas it would be more appropriate to consider the change 
in prevalence for the population aged 15 - 49. However, they 
fail to remedy this error, described by them as ‘some serious 
inaccuracies’, by providing the figures for women aged 15 - 49, 
preferring to argue that the trend implied by differencing the 
prevalence rates from the 2002 and 2008 surveys is ‘in good 
agreement’ with the trend from the antenatal surveys on the 
grounds that 6 of the 9 provinces showed change in the same 
direction. Aside from the fact that the chances of getting such a 
result or better are about 75% if one allocates the up and down 
arrows randomly, their comparison misses the point. It was the 
conclusion, based on the comparison from 2002 that prevalence 
had dropped in 4 provinces, which was at issue. The table with 
the correct figures is reproduced below (Table I). It is interesting 
to note that not only do the corrected figures not change the 
argument, but in the case of 2 of the 4 provinces (Western Cape 
and Gauteng) the differences are even more marked.
Rehle and Shisana also argue that change in overall 
prevalence over the period of the two surveys is very similar. 
The problems with this argument are: (i) as mentioned in the 
footnote to Table I there was a significant change in the sample 
used by the antenatal survey in 2006 and this, if anything, 
probably leads to an underestimate of the trend between 2002 
and 2007; and (ii) the prevalence in 2007 that is comparable to 
the 2002 figure is not 28.0% but 29.3%,1,2 and hence the implied 
increase in prevalence in women attending public antenatal 
clinics is at least 2.8% (which is a good deal higher than the 
1.3% they report for the national household prevalence survey).
It should be noted that none of the points above have been 
argued on the basis of a model (ASSA’s or otherwise). My 
purpose was not to argue that models are better than empirical 
data or that the HSRC survey is wrong (at least not in any way 
that suggested fault on the part of the investigators) or that 
PMTCT and ARV aren’t having an effect or that behaviour 
is not changing towards the less risky, but to suggest that 
interpretation of the results should be more cautious and 
scientific and prepared to acknowledge the limitations of the 
survey.
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Table I. Difference in prevalence (%), 15 - 49 years, HSRC 
(2002 - 2008) v. antenatal surveys (2002 - 2007)
  HSRC survey Antenatal  survey
Province  (2002 - 2008) (2002 - 2007)*
Western Cape          –7.9           +2.9
Northern Cape          –0.6           +1.5
Free State           –0.9           +2.7
Gauteng           –5.1           –1.0
*These values ignore the impact of the expansion of the sample in 2006 which if 
allowed for would probably increase these differences by at least 1% and by as much 
as 3% for the Northern Cape in particular.
